Unilateral Vision Loss After Hyaluronic Acid Injection: A Case Report.
Journal
Annals of plastic surgery
ISSN: 1536-3708
Titre abrégé: Ann Plast Surg
Pays: United States
ID NLM: 7805336
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
22
12
2020
medline:
15
5
2021
entrez:
21
12
2020
Statut:
ppublish
Résumé
Vascular occlusion causing vision loss is a rare yet one of the most devastating complications of facial esthetic fillers. In this article, we present a case of unilateral blindness and superficial skin necrosis in a 31-year-old woman after the injection of hyaluronic acid for esthetic purposes. The delicate ocular fundal findings of ophthalmic artery occlusion were demonstrated by ophthalmoscopy, optical coherence tomography, and fluorescein angiography. Magnetic resonance imaging also showed subsequent ischemic changes in the optic nerve and posterior scleral wall after ophthalmic artery occlusion. Despite management including intraocular pressure-lowering agents, globe massage, and anticoagulation with acetylsalicylic acid and hyperbaric oxygen therapy, her final vision was not restored. Given the lack of effective treatments, this report depicts the comprehensive ocular fundal findings of an ophthalmic artery occlusion after esthetic hyaluronic acid filler injection, and highlights the importance of a preventive approach to avoid such catastrophic complications.
Identifiants
pubmed: 33346533
doi: 10.1097/SAP.0000000000002624
pii: 00000637-202102001-00023
doi:
Substances chimiques
Dermal Fillers
0
Hyaluronic Acid
9004-61-9
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S127-S131Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
DeLorenzi C. Complications of injectable fillers, part I. Aesthet Surg J . 2013;33:561–575.
DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J . 2014;34:584–600.
Urdiales-Gálvez F, Delgado NE, Figueiredo V, et al. Treatment of soft tissue filler complications: expert consensus recommendations. Aesthet Plast Surg . 2018;42:498–510.
Park KH, Kim YK, Woo SJ, et al. Iatrogenic occlusion of the ophthalmic artery after cosmetic facial filler injections: a national survey by the Korean Retina Society. JAMA Ophthalmol . 2014;132:714–723.
Hsieh YH, Lin CW, Huang JS, et al. Severe ocular complications following facial calcium hydroxylapatite injections: two case reports. Taiwan J ophthalmol . 2015;5:36–39.
Chiang YZ, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. J Eur Acad Dermatol Venereol . 2017;31:405–413.
Ortiz AE, Ahluwalia J, Song SS, et al. Analysis of U.S. Food and Drug Administration data on soft-tissue filler complications. Dermatol Surg . 2019;46:958–961.
Sito G, Manzoni V, Sommariva R. Vascular complications after facial filler injection: a literature review and meta-analysis. J Clin Aesthet Dermatol . 2019;12:E65–E72.
Beleznay K, Carruthers JD, Humphrey S, et al. Avoiding and treating blindness from fillers: a review of the world literature. Dermatol Surg . 2015;41:1097–1117.
Scheuer JF 3rd, Sieber DA, Pezeshk RA, et al. Anatomy of the facial danger zones: maximizing safety during soft-tissue filler injections. Plast Reconstr Surg . 2017;139:50e–58e.
Beleznay K, Carruthers JDA, Humphrey S, et al. Update on avoiding and treating blindness from fillers: a recent review of the world literature. Aesthet Surg J . 2019;39:662–674.
Rayess HM, Svider PF, Hanba C, et al. A cross-sectional analysis of adverse events and litigation for injectable fillers. JAMA Facial Plast Surg . 2018;20:207–214.
Thanasarnaksorn W, Cotofana S, Rudolph C, et al. Severe vision loss caused by cosmetic filler augmentation: case series with review of cause and therapy. J Cosmet Dermatol . 2018;17:712–718.
Wibowo A, Kapoor KM, Philipp-Dormston WG. Reversal of post-filler vision loss and skin ischaemia with high-dose pulsed hyaluronidase injections. Aesthet Plast Surg . 2019;43:1337–1344.
DeLorenzi C. Transarterial degradation of hyaluronic acid filler by hyaluronidase. Dermatol Surg . 2014;40:832–841.
Lee W, Oh W, Ko HS, et al. Effectiveness of retrobulbar hyaluronidase injection in an iatrogenic blindness rabbit model using hyaluronic acid filler injection. Plast Reconstr Surg . 2019;144:137–143.
Zhu GZ, Sun ZS, Liao WX, et al. Efficacy of retrobulbar hyaluronidase injection for vision loss resulting from hyaluronic acid filler embolization. Aesthet Surg J . 2017;38:12–22.
Adulkar N, Cheng C, Lee L, et al. An in vitro model assessing the penetration of hyaluronidase through optic nerve dura for management of hyaluronic acid facial filler embolism. Plast Reconstr Surg . 2019;144:43e–47e.
DeLorenzi C. Commentary on: efficacy of retrobulbar hyaluronidase injection for vision loss resulting from hyaluronic acid filler embolization. Aesthet Surg J . 2017;38:23–27.
Tobalem S, Schutz JS, Chronopoulos A. Central retinal artery occlusion—rethinking retinal survival time. BMC Ophthalmol . 2018;18:101.
Lee SH, Ha TJ, Lee JS, et al. Topography of the central retinal artery relevant to retrobulbar reperfusion in filler complications. Plast Reconstr Surg . 2019;144:1295–1300.
Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology . 2010;117:1367–1375.e1.
Lee JS, Kim JY, Jung C, et al. Iatrogenic ophthalmic artery occlusion and retinal artery occlusion. Prog Retin Eye Res . 2020;100848.
Hong WT, Kim J, Kim SW. Minimizing tissue damage due to filler injection with systemic hyperbaric oxygen therapy. Arch Craniofac Surg . 2019;20:246–250.
Hsiao SF, Huang YH. Partial vision recovery after iatrogenic retinal artery occlusion. BMC Ophthalmol . 2014;14:120.